Publications

Showing 161 to 170 of 554 Publications
Title Authors
CCNA Researchers* / CCNA Trainees**
Year Journal
International Parkinson’s Disease Genomics C. Parkinson’s disease age at onset genome-wide association study: Defining heritability, genetic loci, and alpha-synuclein mechanisms. "Blauwendraat, C., Heilbron, K., Vallerga, CL., Bandres-Ciga, S., von Coelln, R., Pihlstrom, L., Simon-Sanchez, J., Schulte, C., Sharma, M., Krohn, L.*, Siitonen, A., Iwaki, H., Leonard, H., Noyce, AJ., Tan, M., Gibbs, JR., Hernandez, DG., Scholz, SW., Jankovic, J., Shulman, LM., Lesage, S., Corvol, JC., Brice, A., van Hilten, JJ., Marinus, J., Eerola-Rautio J., Tienari P., Majamaa K., Toft M., Grosset DG., Gasser, T., Heutink, P., Shulman, JM., Wood, N., Hardy, J., Morris, HR., Hinds, DA., Gratten, J., Visscher, PM., Gan-Or, Z.**, Nalls, MA., Singleton, AB. " 2019 Mov Disord
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Moscoso Rial A, Pascoal TA, Andreasson U, Scholl M, Weiner H, Rosa-Neto P*, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H, for the Alzheimer's Disease Neuroimaging Initiative 2020 Molecular Psychiatry
The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease
Pentz R, Iulita MF, Ducatenzeiler A, Benett DA, Cuello AC* 2020 Molecular Psychiatry
APOEε4 potentiates the relationship between amyloid-β and tau pathologies
Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Savard M, Chamoun M, Thomas E, Kang MS, Lussier F, Tissot C, Soucy JP, Massarweh G, Rej S, Saha-Chaudhuri P, Poirier J*, Gauthier S*, Rosa-Neto P* 2020 Molecular Psychiatry
High-density lipoproteins suppress Abeta-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture Robert, J., Button, E. B., Stukas, S., Boyce, G. K., Gibbs, E., Cowan, C. M., Gilmour, M., Cheng, W. H., Soo, S. K., Yuen, B., Bahrabadi, A., Kang, K., Kulic, I., Francis, G., Cashman, N., & Wellington, C. L. 2017 Molecular Neurodegeneration
Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
Robert J, Button EB, Martin EM, McAlary L, Gidden Z, Boyce G, Caffrey TM, Agbay A, Clark A, Silverman JM, Cashman NR*, Wellington CL* (Team 3) 2020 Molecular Neurodegeneration
Plasma Levels of Phosphorylated Tau 181 Are Associated With Cerebral Metabolic Dysfunction in Cognitively Impaired Individuals
Lussier FZ, Benedet AL, Therriault J, Pascoal TA, Tissot C, Chamoun M, Mathotaarachchi S, Savars M, Ashton NJ, Karikari TK, Rodriguez JL, Snellman A, Bezgin G, Kang MS, Arias JF, Wang YT, Gauthier S*, Zetterberg H, Blennow K, Rosa-Neto P* 2020 Molecular Neurodegeneration
Precocious White Matter Inflammation and Behavioural Inflexibility Precede Learning and Memory Impairment in the TgAPP21 Rat Model of Alzheimer Disease
Levit A, Gibson A, Hough O, Jung Y, Agca Y, Agca C, Hachinski V*, Allman BL, Whitehead SN* 2021 Molecular Neurobiology
Chloroquine Restores Ganglioside Homeostasis and Improves Pathological and Behavioral Outcomes Post-stroke in the Rat. Caughlin, S*, Hepburn, J., Liu, Q., Wang, L., Yeung, KK., Cechetto, DF., Whitehead, SN**. 2019 Molecular neurobiology
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
Ferrari-Souza, J.P., Ferreira, P.C.L., Bellaver, B., Tissot, C., Wang, Y.T., Leffa, D.T., Brum, W.S., Benedet, A.L., Ashton, N.J., De Bastiani, M.A., Rocha, A., Therriault, J., Lussier, F.Z., Chamoun, M., Servaes, S., Bezgin, G., Kang, M.S., Stevenson, J., Rahmouni, N., Pallen, V.**, Poltronetti, N.M., Klunk, W.E., Tudorascu, D.L., Cohen, A., Villemagne, V.L., Gauthier, S.*, Blennow, K., Zetterberg, H., Souza, D.O., Karikari, T.K., Zimmer, E.R., Rosa-Neto, P.*, Pascoal, T.A. 2022 MedRxiv
Showing 161 to 170 of 554 Publications
Go back to top